|
|
| ||
| ||||
|
|
Clin Endocrinol (Oxf). 2006 Jul;65(1):75-80. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance. Topcu S,Tok D, Caliskan M,Ozcimen EE, Gullu H,Uckuyu A,Erdogan D,Zeyneloglu H,Muderrisoglu H. Department of Cardiology, Baskent University, Konya Teaching and Medical Research Centre, Konya, Turkey. Background:Women with polycystic ovary syndrome (PCOS) are thought to have increased cardiovascular risk. Metformin therapy reduces whole-body insulin resistance (IR) in patients with type-2 diabetes mellitus (DM). Objectives:As insulin resistance accompanying PCOS may be reversed by metformin therapy, we hypothesized that metformin therapy might improve coronary microvascular functions in women with PCOS and IR. Patients and |
|
Please subscribe to receive
our FREE women's health newsletter.
STAY UP TO DATE on the important issues affecting YOUR HEALTH.
| |
| First Name: | |
| Family Name: | |
| Email: | |
| Profession: | |
| Country: | |
| Age: | |
DISCLAIMER
The aim of this web site is to provide a general guide and it is not intended as a substitute for a consultation with an appropriate specialist in respect of individual care and treatment.
Thank you for your visiting us at 2womenshealth.com.
This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.
I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.